Intestinal permeability in strongyloidiasis

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 3, 2001, Pages 353-357

  Werneck Silva, A L ^b   Sipahi, A M ^b   Damiao A O M C ^b   Buchpiguel, C A ^a   Iriya, K ^a   Laudanna, A A ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

51Cr EDTA; Intestinal permeability; Small bowel; Strongyloidiasis

Indexed keywords

STRONGYLOIDES STERCORALIS;

CHROMIUM; EDETIC ACID;

ADULT; AGED; ANIMAL; ARTICLE; CASE CONTROL STUDY; FEMALE; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERMEABILITY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; URINE;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CHROMIUM RADIOISOTOPES; EDETIC ACID; FEMALE; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PERMEABILITY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 0035287486     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000300009     Document Type: Article

References (43)

1. Kraehenbuhl J-P, Pringault E & Neutra MR (1997). Intestinal epithelia and barrier functions. Alimentary Pharmacology and Therapeutics, 11 (Suppl 3): 3-9.
2. Sartor RB (1995). Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterology Clinics of North America, 3: 475-507.
3. 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scandinavian Journal of Gastroenterology, 24: 993-998.
4. 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology, 85: 318-322.
5. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T & Rotter JI (1986). Increased intestinal permeability in patients with Crohn's disease and their relatives. Annals of Internal Medicine, 105: 883-885.
6. Hollander D (1988). Crohn's disease - a permeability disorder of the tight junction? Gut, 29: 1621-1624.
7. Hollander D (1992). The intestinal permeability barrier: a hypothesis as to its regulation and involvement in Crohn's disease (Review). Scandinavian Journal of Gastroenterology, 27: 721-726.
8. 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. American Journal of Gastroenterology, 82: 1159-1164.
9. 51Cr-EDTA in patients with active inflammatory bowel disease. Clinical and Investigative Medicine, 11: 151-155.
10. 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. Journal of Laboratory and Clinical Medicine, 108: 430-435.
11. 51Cr-ethylenediaminetetraacetate in patients with ulcerative colitis. American Journal of Gastroenterology, 88: 1978-1979.
12. 51Cr] EDTA in children with acute gastroenteritis or eczema. Journal of Pediatric Gastroenterology and Nutrition, 4: 393-396.
13. Bjarnason I, Marsh MN, Price A, Levi AJ & Peters TJ (1985). Intestinal permeability in patients with coelic disease and dermatitis herpetiformis. Gut, 26: 1214-1219.
14. 51Cr-EDTA and orocecal transit time in cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition, 14: 204-207.
15. 51Cr]-EDTA in children with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition, 5: 384-387.
16. Bjarnason I, Wark K & Peters TJ (1984). The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet, 1: 179-182.
17. 51Cr-ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, anti-inflammatory drug. Scandinavian Journal of Gastroenterology, 25: 917-924.
18. Bjarnason I, So A, Levi AJ, Peters TJ, Williams P, Zanelli GD, Gumpel JM & Ansell B (1984). Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet, 2: 1171-1173.
19. Bjarnason I, Williams P, Smerthurst P, Peters TJ & Levi AJ (1986). Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut, 27: 1292-1297.
20. Jenkins AP, Trew DR, Crump BJ, Nukajam WS, Foley JA, Menzies IS & Creamer B (1991). Do non-steroidal anti-inflammatory drugs increase colonic permeability? Gut, 32: 66-69.
21. 51Cr] EDTA in infectious diarrhea. Digestive Diseases and Sciences, 38: 1651-1657.
22. Zuckerman MJ, Watts MT, Ho H & Meriano FV (1994). Blastocystis hominis infection and intestinal injury. American Journal of the Medical Sciences, 308: 96-101.
23. De Paola D, Braga-Dias L & Silva JR (1962). Enteritis due to Strongyloides stercoralis. American Journal of Digestive Diseases, 7: 1086-1098.
24. Britt DP, Khan HA & Florentino AO (1989). Strongyloides infection in an immunosuppressed patient. Medical Principles and Practice, 1: 63-64.
25. Cook GC (1987). Strongyloides stercoralis hyperinfection syndrome: how often is it missed? Quarterly Journal of Medicine, 244: 625-629.
26. Purtilo DT, Meyers WM & Connor DH (1974). Fatal strongyloidiasis in immunosuppressed patients. American Journal of Medicine, 56: 488-493.
27. Sipahi AM, Damião AOMC, Simionato CS, Bonini N, Santos MAA, Moraes-Filho JPP, Laudanna AA & Betarello A (1991). Small bowel bacterial overgrowth in strongyloidiasis. Digestion, 49: 120-124.
28. Igra-Siegman Y, Kapila R, Sen P, Kaminski Z & Louria DB (1981). Syndrome of hyper-infection with Strongyloides stercoralis. Reviews of Infectious Diseases, 3: 397-407.
29. Rugai E, Mattos T & Brisola AP (1954). Nova técnica para isolar larvas de nematóides das fezes. Modificação do método de Baermann. Memórias do Instituto Adolfo Lutz, 14: 5-8.
30. Faust EC (1939). Human Helminthology. 2nd edn. Lea & Febiger, Philadelphia.
31. Hoffmann WA, Pons JA & Janer JL (1934). The sedimentation-concentration method in Schistosomiasis mansoni. Puerto Rico Journal of Health and Tropical Medicine, 9: 283-294.
32. 51Cr-labelled EDTA absorption test. Lancet, 1: 323-325.
33. 51Cr-ethylenediaminetetraacetic acid absorption test. Methodologic aspects. Scandinavian Journal of Gastroenterology, 24: 351-358.
34. 51Cr] EDTA and inflammatory activity in asymptomatic patients with Crohn's disease. Digestive Diseases and Sciences, 35: 582-588.
35. 51Cr-EDTA. American Journal of Gastroenterology, 80: 770-773.
36. 51Cr-EDTA. Arquivos de Gastroenterologia, 33: 66-73.
37. Ukabam SO, Homeida MMA & Cooper BT (1986). Small intestinal permeability in normal Sudanese subjects: evidence of tropical enteropathy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80: 204-207.
38. Menzies IS, Zuckerman MJ, Nukajam WS, Somasundaram SG, Murphy B, Jenkins AP, Crane RS & Gregory GG (1999). Geography of intestinal permeability and absorption. Gut, 44: 483-489.
39. Faust EC (1935). The pathology of Strongyloides infection. Archives of Pathology, 19: 769-806.
40. Da Costa LR (1971). Small intestinal cell turnover in patients with parasitic infections. British Medical Journal, 3: 281-283.
41. Garcia FT, Sessions JT, Strum WB, Schweistris E, Tripathy K, Bolaños O, Lotero H, Duque E, Ramelli D & Mayoral LG (1977). Intestinal function and morphology in strongyloidiasis. American Journal of Tropical Medicine and Hygiene, 26: 859-865.
42. 51Cr-labelled ethylenediaminetetraacetic acid in healthy subjects. Scandinavian Journal of Gastroenterology, 31: 254-259.
43. Laudanna AA, Polak M, Bettarello A & Kieffer J (1973). Evidence of protein-losing enteropathy in strongyloidiasis. Revista do Instituto de Medicina Tropical de São Paulo, 15: 222-226.